Genomic Vision Société Anonyme

LSE:0QT4 Stock Report

Market Cap: €692.9k

Genomic Vision Société Anonyme Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Aaron Bensimon

Chief executive officer

€270.6k

Total compensation

CEO salary percentage92.4%
CEO tenure20yrs
CEO ownershipn/a
Management average tenure1.5yrs
Board average tenure1.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Aaron Bensimon's remuneration changed compared to Genomic Vision Société Anonyme's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

-€11m

Mar 31 2023n/an/a

-€9m

Dec 31 2022€271k€250k

-€7m

Sep 30 2022n/an/a

-€6m

Jun 30 2022n/an/a

-€5m

Mar 31 2022n/an/a

-€5m

Dec 31 2021€323k€250k

-€5m

Sep 30 2021n/an/a

-€5m

Jun 30 2021n/an/a

-€5m

Mar 31 2021n/an/a

-€5m

Dec 31 2020€378k€250k

-€5m

Sep 30 2020n/an/a

-€5m

Jun 30 2020n/an/a

-€5m

Mar 31 2020n/an/a

-€5m

Dec 31 2019€308k€250k

-€5m

Sep 30 2019n/an/a

-€5m

Jun 30 2019n/an/a

-€6m

Mar 31 2019n/an/a

-€6m

Dec 31 2018€305k€250k

-€7m

Compensation vs Market: Aaron's total compensation ($USD294.82K) is about average for companies of similar size in the UK market ($USD348.98K).

Compensation vs Earnings: Aaron's compensation has been consistent with company performance over the past year.


CEO

Aaron Bensimon

20yrs

Tenure

€270,611

Compensation

Mr. Aaron Bensimon, Ph D., Co-Founded Genomic Vision Société Anonyme in 2004 and serves as Chairman of the Executive Board since July 11, 2022 and also serves as its Chief Executive Officer since September...


Leadership Team

NamePositionTenureCompensationOwnership
Aaron Bensimon
Co-Founder20yrs€270.61kno data
Lionel Seltz
Administrative & Financial Director and Member of the Management Boardno data€50.73kno data
Emilie Chataignier
Member of Executive Board1.5yrs€8.40kno data
Frederic Hammel
Chief Operating Officerless than a yearno datano data
Mark Lynch
Global Commercial & Marketing Director2.8yrsno datano data
Claire Fleury
Director of Human Resourcesless than a yearno datano data

1.5yrs

Average Tenure

Experienced Management: 0QT4's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Daniel Louvard
Member of Scientific Advisory Boardno datano datano data
Nicolas Levy
Member of Scientific Advisory Boardno datano datano data
Judith Melki
Member of Scientific Advisory Boardno datano datano data
Jonathan Weizman
Member of Scientific Advisory Boardno datano datano data
Florence Alouch
Chair of Supervisory Board1.5yrs€25.00kno data
Eric Edery
Vice-President of Supervisory Board1.5yrs€7.00kno data
Mohammed Afshar
Member of Supervisory Board1.5yrs€5.00kno data

1.5yrs

Average Tenure

Experienced Board: 0QT4's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/22 05:55
End of Day Share Price 2023/10/25 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genomic Vision Société Anonyme is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hugo SolvetBryan Garnier & Co
Lionel LabourdetteKepler Cheuvreux
Delphine Le LouetSociete Generale Cross Asset Research